Corrigendum: Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer
Anli Yang, Ying Zhou, Yanan Kong, Xiaoli Wei, Feng Ye, Lijuan Zhang, Xian Zhong, Mingyue Li, Shilin Lu, Xin An, Weikai Xiao
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEpigenetics and DNA Methylation · Ferroptosis and cancer prognosis · Cancer Immunotherapy and Biomarkers
In the published article, there was an error regarding the affiliations for Weikai Xiao. The affiliation of Weikai Xiao should only be 7, but not 1.
In the published article, there was also an error in the Funding statement. This previously stated: The approval number of the National Natural Science Foundation of China was displayed as “8203066”. And the approval number of Guangzhou basic and applied basic research project (approved in 2021).
The correct Funding statement appears below.
FUNDING
This research is funded by the National Natural Science Foundation of China (approval No.: 82003066), Guangzhou basic and applied basic research project (202102020168), and special science and Technology Fund (Doctoral entrepreneurship project) of Guangdong People’s Hospital and Guangdong Provincial Medical Research Fund (a2021080).
The authors apologize for these error and state that they do not change the scientific conclusions of the article in any way. The original article has been updated.